The companies are tapping a longstanding partnership and said they would finalize financial details and terms in the coming weeks. The effort will involve using neutralizing antibodies against SARS-CoV-2 from hundreds of Covid-19 patients.

LEAVE A REPLY

Please enter your comment!
Please enter your name here